Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2007 2
2008 2
2009 1
2010 2
2011 2
2012 4
2013 3
2014 3
2015 2
2016 2
2017 1
2018 2
2019 4
2020 3
Text availability
Article attribute
Article type
Publication date

Search Results

33 results
Results by year
Filters applied: . Clear all
Page 1
Influenza and Bacterial Superinfection: Illuminating the Immunologic Mechanisms of Disease.
Rynda-Apple A, Robinson KM, Alcorn JF. Rynda-Apple A, et al. Infect Immun. 2015 Oct;83(10):3764-70. doi: 10.1128/IAI.00298-15. Epub 2015 Jul 27. Infect Immun. 2015. PMID: 26216421 Free PMC article. Review.
IFNAR2 Is Required for Anti-influenza Immunity and Alters Susceptibility to Post-influenza Bacterial Superinfections.
Shepardson KM, Larson K, Johns LL, Stanek K, Cho H, Wellham J, Henderson H, Rynda-Apple A. Shepardson KM, et al. Front Immunol. 2018 Nov 9;9:2589. doi: 10.3389/fimmu.2018.02589. eCollection 2018. Front Immunol. 2018. PMID: 30473701 Free PMC article.
Tolerance in the absence of autoantigen.
Pascual DW, Ochoa-Repáraz J, Rynda A, Yang X. Pascual DW, et al. Among authors: rynda a. Endocr Metab Immune Disord Drug Targets. 2007 Sep;7(3):203-10. doi: 10.2174/187153007781662549. Endocr Metab Immune Disord Drug Targets. 2007. PMID: 17897047 Review.
Contributions of Influenza Virus Hemagglutinin and Host Immune Responses Toward the Severity of Influenza Virus: Streptococcus pyogenes Superinfections.
Klonoski JM, Watson T, Bickett TE, Svendsen JM, Gau TJ, Britt A, Nelson JT, Schlenker EH, Chaussee MS, Rynda-Apple A, Huber VC. Klonoski JM, et al. Viral Immunol. 2018 Jul/Aug;31(6):457-469. doi: 10.1089/vim.2017.0193. Epub 2018 Jun 5. Viral Immunol. 2018. PMID: 29870311 Free PMC article.
Contribution of Host Immune Responses Against Influenza D Virus Infection Toward Secondary Bacterial Infection in a Mouse Model.
Skelton RM, Shepardson KM, Hatton A, Wilson PT, Sreenivasan C, Yu J, Wang D, Huber VC, Rynda-Apple A. Skelton RM, et al. Viruses. 2019 Oct 29;11(11):994. doi: 10.3390/v11110994. Viruses. 2019. PMID: 31671825 Free PMC article.
A Self-Adjuvanted, Modular, Antigenic VLP for Rapid Response to Influenza Virus Variability.
Sharma J, Shepardson K, Johns LL, Wellham J, Avera J, Schwarz B, Rynda-Apple A, Douglas T. Sharma J, et al. ACS Appl Mater Interfaces. 2020 Apr 22;12(16):18211-18224. doi: 10.1021/acsami.9b21776. Epub 2020 Apr 13. ACS Appl Mater Interfaces. 2020. PMID: 32233444
A live diarrheal vaccine imprints a Th2 cell bias and acts as an anti-inflammatory vaccine.
Jun S, Gilmore W, Callis G, Rynda A, Haddad A, Pascual DW. Jun S, et al. Among authors: rynda a. J Immunol. 2005 Nov 15;175(10):6733-40. doi: 10.4049/jimmunol.175.10.6733. J Immunol. 2005. PMID: 16272329 Free article.
Low-dose tolerance is mediated by the microfold cell ligand, reovirus protein sigma1.
Rynda A, Maddaloni M, Mierzejewska D, Ochoa-Repáraz J, Maslanka T, Crist K, Riccardi C, Barszczewska B, Fujihashi K, McGhee JR, Pascual DW. Rynda A, et al. J Immunol. 2008 Apr 15;180(8):5187-200. doi: 10.4049/jimmunol.180.8.5187. J Immunol. 2008. PMID: 18390700 Free PMC article.
Virus-like particles as antigenic nanomaterials for inducing protective immune responses in the lung.
Rynda-Apple A, Patterson DP, Douglas T. Rynda-Apple A, et al. Nanomedicine (Lond). 2014;9(12):1857-68. doi: 10.2217/nnm.14.107. Nanomedicine (Lond). 2014. PMID: 25325241 Free PMC article. Review.
[Complex treatment of a patient with neurofibromatosis type 2].
Rynda AY, Olyushin VE, Rostovtsev DM, Zabrodskaya YM. Rynda AY, et al. Zh Nevrol Psikhiatr Im S S Korsakova. 2020;120(8):98-104. doi: 10.17116/jnevro202012008198. Zh Nevrol Psikhiatr Im S S Korsakova. 2020. PMID: 32929931 Russian.
33 results
Jump to page
Feedback